Search research articles
Contact Us
Filters
Showing results (141-150 of 165) with videos related to
Page
of 17
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 13, 2024
LRRC8A as a central mediator promotes colon cancer metastasis by regulating PIP5K1B/PIP2 pathway
Haifeng Zhang, Rong Liu, Zhenghui Jing, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2012
Characterization of MADS-domain transcription factor complexes in Arabidopsis flower development
Cezary Smaczniak, Richard G H Immink, Jose M Muiño, et al.
Pigment Cell & Melanoma Research
|
April 24, 2015
miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
Shujing Liu, Michael T Tetzlaff, Tao Wang, et al.
Cancer Immunology Research
|
June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells
Shujing Liu, Alain H Rook, Alexander C Huang, et al.
Cell Reports
|
May 24, 2016
Oncogenic BRAF-Mediated Melanoma Cell Invasion
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
The American Journal of Pathology
|
October 31, 2024
Programmed Death Ligand-1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage Polarization
Lili Huang, Jingbo Yang, Jinjin Zhu, et al.
Ebiomedicine
|
May 25, 2023
Patient-derived melanoma organoid models facilitate the assessment of immunotherapies
Lingling Ou, Shujing Liu, Huaishan Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 12, 2025
DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicity
Huaishan Wang, Shujing Liu, Prithvi Sinha, et al.
JCI Insight
|
October 24, 2022
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma
Gaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
JCI Insight
|
August 12, 2020
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma
Gaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 165) with videos related to
Sort By:
Page
of 17
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 13, 2024
LRRC8A as a central mediator promotes colon cancer metastasis by regulating PIP5K1B/PIP2 pathway
Haifeng Zhang, Rong Liu, Zhenghui Jing, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2012
Characterization of MADS-domain transcription factor complexes in Arabidopsis flower development
Cezary Smaczniak, Richard G H Immink, Jose M Muiño, et al.
Pigment Cell & Melanoma Research
|
April 24, 2015
miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
Shujing Liu, Michael T Tetzlaff, Tao Wang, et al.
Cancer Immunology Research
|
June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells
Shujing Liu, Alain H Rook, Alexander C Huang, et al.
Cell Reports
|
May 24, 2016
Oncogenic BRAF-Mediated Melanoma Cell Invasion
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
The American Journal of Pathology
|
October 31, 2024
Programmed Death Ligand-1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage Polarization
Lili Huang, Jingbo Yang, Jinjin Zhu, et al.
Ebiomedicine
|
May 25, 2023
Patient-derived melanoma organoid models facilitate the assessment of immunotherapies
Lingling Ou, Shujing Liu, Huaishan Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 12, 2025
DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicity
Huaishan Wang, Shujing Liu, Prithvi Sinha, et al.
JCI Insight
|
October 24, 2022
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma
Gaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
JCI Insight
|
August 12, 2020
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma
Gaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
Page
of 17